Impact of Margin-accentuation IRE in Pancreatic Cancer
NCT02952859
·
clinicaltrials.gov ↗
TERMINATED
Status
26
Enrollment
OTHER
Sponsor class
Stopped
PI left hospital
Conditions
Pancreatic Cancer
Interventions
OTHER:
Irreversible electroporation
Sponsor
Insel Gruppe AG, University Hospital Bern